Elevated cancer incidence in patients with dermatomyositis: a population based study - PubMed (original) (raw)
Affiliations
- PMID: 7562762
Elevated cancer incidence in patients with dermatomyositis: a population based study
A Airio et al. J Rheumatol. 1995 Jul.
Abstract
Objective: To study the relationship of polymositis (PM) and dermatomyositis (DM) and cancer in Finland.
Methods: The medical records of 175 patients with PM and 71 with DM diagnosed between 1969 and 1985 were reviewed. The patients were followed until death or until December 30, 1990 through the files of Statistics Finland and the Finnish Cancer Registry.
Results: Thirty-four cases of cancer were found [standardized incidence ratio (SIR) 2.1, 95% confidence interval 1.4-2.9]. In the PM group the SIR was 1.0 (95% CI 0.5-1.8), and in the DM group 6.5 (95% CI 3.9-10). The relative risk of cancer among DM cases was very high (SIR 26, 12-48) in the first year after DM diagnosis.
Conclusion: DM is associated with cancer, but not PM. The risk is high among patients with DM older than 49. Cytotoxic drugs given to DM patients did not increase the risk of malignancies. DM and certain cancers seem to share etiological factors.
Similar articles
- Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study.
Stockton D, Doherty VR, Brewster DH. Stockton D, et al. Br J Cancer. 2001 Jul 6;85(1):41-5. doi: 10.1054/bjoc.2001.1699. Br J Cancer. 2001. PMID: 11437400 Free PMC article. - Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study.
Kuo CF, See LC, Yu KH, Chou IJ, Chang HC, Chiou MJ, Luo SF. Kuo CF, et al. Br J Dermatol. 2011 Dec;165(6):1273-9. doi: 10.1111/j.1365-2133.2011.10595.x. Epub 2011 Nov 3. Br J Dermatol. 2011. PMID: 21895620 - Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study.
Huang YL, Chen YJ, Lin MW, Wu CY, Liu PC, Chen TJ, Chen YC, Jih JS, Chen CC, Lee DD, Chang YT, Wang WJ, Liu HN. Huang YL, et al. Br J Dermatol. 2009 Oct;161(4):854-60. doi: 10.1111/j.1365-2133.2009.09274.x. Epub 2009 Apr 30. Br J Dermatol. 2009. PMID: 19558555 - Dermatomyositis and ovarian cancer: a report of 7 cases and literature review.
Cherin P, Piette JC, Herson S, Bletry O, Wechsler B, Frances C, Godeau P. Cherin P, et al. J Rheumatol. 1993 Nov;20(11):1897-9. J Rheumatol. 1993. PMID: 8308775 Review. - Risk of Malignancy in Dermatomyositis and Polymyositis.
Qiang JK, Kim WB, Baibergenova A, Alhusayen R. Qiang JK, et al. J Cutan Med Surg. 2017 Mar/Apr;21(2):131-136. doi: 10.1177/1203475416665601. Epub 2016 Aug 20. J Cutan Med Surg. 2017. PMID: 27534779 Review.
Cited by
- [Epidemiological profile of dermatomyositis and polymyositis: a study conducted in the Department of Rheumatology in Marrakech].
Errafia S, Mougui A, Bouchti IE. Errafia S, et al. Pan Afr Med J. 2021 Jan 29;38:101. doi: 10.11604/pamj.2021.38.101.25406. eCollection 2021. Pan Afr Med J. 2021. PMID: 33889267 Free PMC article. French. - [Clinical analysis of 11 cases of lymphoma complicated with paraneoplastic neurological syndrome].
Wei C, Zhao DQ, Zhang Y, Wang W, Zhang W, Zhou DB. Wei C, et al. Zhonghua Xue Ye Xue Za Zhi. 2022 Apr 14;43(4):311-315. doi: 10.3760/cma.j.issn.0253-2727.2022.04.008. Zhonghua Xue Ye Xue Za Zhi. 2022. PMID: 35680630 Free PMC article. Chinese. - Risk factors for tumor occurrence in patients with myasthenia gravis.
Citterio A, Beghi E, Millul A, Evoli A, Mantegazza R, Antozzi C, Baggi F, Cornelio F, Durelli L, Clerico M, Piccolo G, Cosi V. Citterio A, et al. J Neurol. 2009 Aug;256(8):1221-7. doi: 10.1007/s00415-009-5091-9. Epub 2009 Mar 29. J Neurol. 2009. PMID: 19330280 - Dermatomyositis as the first manifestation of gallbladder adenocarcinoma: case report and literature overview.
Jurcic P. Jurcic P. World J Surg Oncol. 2015 Mar 27;13:127. doi: 10.1186/s12957-015-0535-4. World J Surg Oncol. 2015. PMID: 25890241 Free PMC article. Review. - Concurrence of ovarian cancer and dermatomyositis: a propensity score analysis.
Cheng H, Huo L, Wang D, Xiang Y. Cheng H, et al. J Gynecol Oncol. 2019 Nov;30(6):e99. doi: 10.3802/jgo.2019.30.e99. J Gynecol Oncol. 2019. PMID: 31576691 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical